All lobbying filings

HARBINGER STRATEGIES, LLC

Lobbying for GENENTECH, INC. · Biotech company developing medicines to treat patients.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 21, 2026

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Taxation/Internal Revenue Code

Issues related to corporate taxation including corporate rate; deductibility of research and development expenses; and international taxation (Foreign Derived Intangible Income). P.L. 119-21.

Health Issues

Issues related to drug pricing. Issues related to the 340B Drug Discount Program.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.